IL-23 receptor antagonist (Oscotec)

N/A

Report date: 2025/02/01 20:00:06

NME

Base Information

Drug NameIL-23 receptor antagonist (Oscotec)

Drug Alias NameN/A

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionInterleukin-23 inhibitors

TargetsInterleukin-23

Therapy Area/IndicationsArthritis

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritorySouth Korea

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesOscotec Inc

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesOscotec Inc

Active IndicationsN/A

Inactive IndicationsArthritis

ATC CodeN/A